What Rituxan treats
Rituxan (rituximab) is a biologic medication used to treat various autoimmune conditions and certain types of cancer. It is commonly prescribed for moderate to severe rheumatoid arthritis, certain types of non-Hodgkin lymphoma, chronic lymphocytic leukemia (CLL), and granulomatosis with polyangiitis. Rituxan works by targeting and depleting specific B cells involved in disease processes.
Benefits of Rituxan
Patients using Rituxan often experience significant benefits, including reduced disease activity, fewer disease flares, and improved symptoms such as joint pain and swelling in rheumatoid arthritis. For cancer patients, Rituxan can lead to tumor reduction and improved disease management. The infusion schedule allows for ongoing treatment with regular monitoring of disease response and side effects.
Possible Side Effects of Rituxan
While Rituxan is generally effective, some patients may experience side effects, including infusion-related reactions such as fever, chills, and nausea. Other potential side effects include infections, fatigue, and skin rashes. Serious side effects can include an increased risk of severe infections, including hepatitis B reactivation, and rare but severe conditions such as progressive multifocal leukoencephalopathy (PML). It is important to monitor for any adverse effects and report them to your healthcare provider.
How infusion works at Prime
Rituxan is administered at our infusion centers across New York and Atlanta. Our dedicated care team coordinates every step of your treatment with your prescribing physician.
Getting started
Patients: if you have a referral for Rituxan, send us an inquiry using the form below and our care team will take it from there. Physicians: referring a patient to Prime Infusions is simple — just complete and fax or email the referral form above.
Ready to start?
For a medical emergency, call 911.
Our Infusion Centers
FAQ
Frequently asked questions
How Does Rituxan Work?
Rituxan works by binding to CD20, a protein found on the surface of B cells. This binding leads to the destruction of these B cells through multiple mechanisms, including antibody-dependent cellular cytotoxicity and complement-mediated cytotoxicity. By depleting CD20-positive B cells, Rituxan helps reduce inflammation and manage symptoms in autoimmune diseases, as well as target cancerous cells in specific types of lymphoma and leukemia. Rituxan is administered through intravenous infusion, with dosing schedules tailored to the condition being treated.
Who is Rituxan For?
Rituxan is suitable for adults with moderate to severe rheumatoid arthritis who have not responded adequately to other DMARDs or biologics. It is also prescribed for patients with non-Hodgkin lymphoma, chronic lymphocytic leukemia (CLL), and granulomatosis with polyangiitis. Rituxan is recommended for individuals who need targeted therapy to manage autoimmune symptoms or treat certain cancers.